Nilotinib for the treatment of chronic myeloid leukemia

TD Kim, B Dörken, P Le Coutre - Expert Review of Hematology, 2008 - Taylor & Francis
The introduction of targeted therapy has revolutionized the treatment of chronic myeloid
leukemia (CML). The pivotal role of the Philadelphia chromosome, resulting from the …
被引用次数：7 相关文章

Nilotinib for the treatment of chronic myeloid leukemia.

TD Kim, B Dörken, P le Coutre - Expert Review of Hematology, 2008 - europepmc.org
The introduction of targeted therapy has revolutionized the treatment of chronic myeloid
leukemia (CML). The pivotal role of the Philadelphia chromosome, resulting from the …

Nilotinib for the treatment of chronic myeloid leukemia

TD Kim, B Dorken, P le Coutre - Expert Review of Hematology, 2008 - go.gale.com
Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder that accounts for
approximately 15% of all adult leukemias in the Western world. The incidence is one or two …

Nilotinib for the treatment of chronic myeloid leukemia

TD Kim, B Dörken, P le Coutre - Expert review of …, 2008 - pubmed.ncbi.nlm.nih.gov
The introduction of targeted therapy has revolutionized the treatment of chronic myeloid
leukemia (CML). The pivotal role of the Philadelphia chromosome, resulting from the …

Nilotinib for the treatment of chronic myeloid leukemia

TD Kim, B Dörken, P Le Coutre - Expert Review of …, 2008 - search.proquest.com
The introduction of targeted therapy has revolutionized the treatment of chronic myeloid
leukemia (CML). The pivotal role of the Philadelphia chromosome, resulting from the …